The Drugging of the Americas: How Multinational Drug Companies Say One Thing about Their Products to Physicians in the United States, and Another Thing to Physicians in Latin America

The Drugging of the Americas examines the stark differences in how multinational pharmaceutical companies present their products to physicians in the United States versus Latin America. The study highlights how drug companies provide detailed, rigorous, and well-regulated information to U.S. physicians through FDA-approved sources like the Physicians’ Desk Reference (PDR), ensuring claims about efficacy, contraindications, and side effects are based on scientific evidence. In contrast, the ...